Cohance Lifesciences Limited Share Price & Analysis
₹431.1▲ +1.36%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹431.1
+1.36%
Open
₹—
High
₹448
Low
₹426
Close
₹431.1
52W High
₹1,121
52W Low
₹267
Volume
1591K
Lot Size
1
Sector
Healthcare
Market Cap
₹16K Cr
Face Value
₹1
Mid CapNIFTY 500SMALLCAP 100
Price Chart
Fundamentals
P/E
83.2
Sector P/E
48.9
P/B
4.2
EPS
₹4.68
ROE
7.04%
ROCE
8.35%
D/E Ratio
0.1
Div Yield
0%
Book Value
₹102
+
Strengths
- ✓Low debt relative to equity (D/E 0.1x)
−
Concerns
- ✗Premium to sector peers (P/E 83.2x vs industry 48.9x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
COHANCE · as of Mar 2026
Promoters50.10%
FII11.05%▲0.21
DII16.60%▼0.07
Public22.24%▼0.13
Govt0.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 60.00% | 50.10% | 50.10% | 50.10% | 50.10% | 50.10% |
| FII | 10.14% | 9.54% | 9.80% | 10.70% | 10.84% | 11.05% |
| DII | 15.94% | 17.24% | 17.42% | 16.95% | 16.67% | 16.60% |
| Public | 13.93% | 23.11% | 22.67% | 22.26% | 22.37% | 22.24% |
| Govt | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Corporate Events
Annual General Meeting
AGM5 Aug 2024
Annual General Meeting
AGM11 Dec 2023
About Cohance Lifesciences Limited
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Cohance Lifesciences Limited share price today?▾
Cohance Lifesciences Limited (COHANCE) is currently trading at ₹431.1 on NSE, up 1.36% as of the last market session. Prices update daily after market close on MarketNetra.
Is Cohance Lifesciences Limited available in F&O (Futures & Options)?▾
Yes, Cohance Lifesciences Limited (COHANCE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Cohance Lifesciences Limited 52-week high and low?▾
Cohance Lifesciences Limited's 52-week high is ₹1,121 and the 52-week low is ₹267. The current price of ₹431.1 is 61.5% below the 52W high.
What is Cohance Lifesciences Limited P/E ratio?▾
Cohance Lifesciences Limited's current P/E ratio is 83.2. This indicates the market is paying ₹83.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Cohance Lifesciences Limited options?▾
Cohance Lifesciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade COHANCE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.